Skip to content
OpenCapital
Get started

BIO-key International, Inc. BKYI Q4 2024 earnings

Reported March 27, 2025 · Before market open

Revenue$1.5MMiss by $1.0MDiluted EPS-$0.53Miss by $0.18
Revenue estimate$2.5M
EPS estimate-$0.35

Next report

Date not yet announced

Versus estimates

Revenue

Q1 2026$2.1MMiss by $54.5KQ4 2025$1.2MMiss by $958.7KQ3 2025$1.5MMiss by $250.3KQ2 2025$1.7MMiss by $103.1KQ1 2025$1.6MBeat by $307.2K
Q4 2024$1.5MMiss by $1.0M

Diluted EPS

Q1 2026-$0.15Beat by $0.45Q4 2025-$0.19Miss by $0.12Q3 2025-$0.15Miss by $0.03Q2 2025-$0.20Miss by $0.08Q1 2025-$0.16Beat by $0.08
Q4 2024-$0.53Miss by $0.18

Ask the moment BIO-key International, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did BIO-key International, Inc. report Q4 2024 earnings?
BIO-key International, Inc. (BKYI) reported Q4 2024 earnings on March 27, 2025 before market open.
What were BIO-key International, Inc.'s Q4 2024 revenue and EPS?
BIO-key International, Inc. reported revenue of $1.5M and diluted EPS of $-0.53 for Q4 2024.
Did BIO-key International, Inc. beat estimates in Q4 2024?
Revenue missed the consensus estimate of $2.5M by $1.0M. EPS missed the consensus estimate of $-0.35 by $0.18.